JAK2 (V617F) mutation in healthy individuals

被引：28
|
作者：
Passamonti, Francesco [1 ]
Rumi, Elisa
Pietra, Daniela
Lazzarino, Mario
Cazzola, Mario
机构：
[1] Fdn IRCCS, Dept Haematol, Policlin San Matteo, Pavia, Italy
[2] Univ Pavia, Sch Med, I-27100 Pavia, Italy
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2007年 / 136卷 / 04期
关键词：
polycythaemia vera; essential thrombocythaemia; myelofibrosis; JAK2; V617F; chronic myeloproliferative disorders;
D O I：
10.1111/j.1365-2141.2006.06483.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：678 / 679
页数：3
相关论文
共 50 条
  • [41] Rapid detection of JAK2 V617F mutation in myeloproliferative disorders
    Mir, Rashid
    AbuDuhier, Faisal M.
    ANNALS OF ONCOLOGY, 2016, 27
  • [42] The V617F mutation of JAK2 is very uncommon in patients with thrombosis
    Remacha, Angel F.
    Estivill, Camino
    Pilar Sarda, M.
    Mateo, Jose
    Carles Souto, Joan
    Canals, Carme
    Nomdedeu, Josep
    Fontcuberta, Jordi
    HAEMATOLOGICA, 2007, 92 (02) : 285 - 286
  • [43] New advances in the role of JAK2 V617F mutation in myeloproliferative neoplasms
    Zhang, Yongchao
    Zhao, Yue
    Liu, YuSi
    Zhang, Minyu
    Zhang, Jihong
    CANCER, 2024, 130 (24) : 4229 - 4240
  • [44] The JAK2 V617F Mutation in Pediatric Myeloproliferative Neoplasms: How and When?
    Langabeer, Stephen E.
    Smith, Owen P.
    McMahon, Corrina
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2014, 31 (02) : 138 - 139
  • [45] JAK2 V617F Mutation Prevalence in Myeloproliferative Neoplasms in Pernambuco, Brazil
    da Silva, Rafael Ramos
    Domingues Hatzlhofer, Betania Lucena
    de Faria Machado, Cintia Gonsalves
    de Melo Lima, Aleide Santos
    de Albuquerque, Dulcineia Martins
    Nunes dos Santos, Magnun Nueldo
    Fertrin, Kleber Yotsumoto
    Costa, Fernando Ferreira
    Araujo, Aderson da Silva
    Cavalcanti Bezerra, Marcos Andre
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2012, 16 (07) : 802 - 805
  • [46] Somatic mutation of the V617F JAK2 gene in patients of the cardiovascular diseases
    Olkhovskiy, I. A.
    Gorbenko, A. S.
    Stolyar, M. A.
    Grischenko, D. A.
    Tkachenko, O. A.
    Martsinkevich, T. L.
    TERAPEVTICHESKII ARKHIV, 2019, 91 (07) : 25 - 28
  • [47] DOES ALLELE BURDEN IMPORT IN MYELOFIBROSIS WITH JAK2 V617F MUTATION?
    Maria Isabel, Montero Cuadrado
    Francisco Jose, Marquez Malaver
    Cruz Estrella, Carrillo
    Canale Silvia, Garcia
    Lucia, Mezquita
    Javier, Delgado
    Caro Rocio, Marin
    Francisco Jose, Martin Dominguez
    Nancy, Rodriguez
    Campos Jose, Gonzalez
    Jose Francisco, Falantes
    Jose Antonio, Perez Simon
    HAEMATOLOGICA, 2021, 106 (10) : 258 - 258
  • [48] Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders
    Jones, AV
    Kreil, S
    Zoi, K
    Waghorn, K
    Curtis, C
    Zhang, LY
    Score, J
    Seear, R
    Chase, AJ
    Grand, FH
    White, H
    Zoi, C
    Loukopoulos, D
    Terpos, E
    Vervessou, EC
    Schultheis, B
    Emig, M
    Ernst, T
    Lengfelder, E
    Hehlmann, R
    Hochhaus, A
    Oscier, D
    Silver, RT
    Reiter, A
    Cross, NCP
    BLOOD, 2005, 106 (06) : 2162 - 2168
  • [49] Occurrence of the JAK2 V617F mutation in the Budd-Chiari syndrome
    Colaizzo, Donatella
    Amitrano, Lucio
    Tiscia, Giovanni L.
    Iannaccone, Luigi
    Gallone, Anna
    Grandone, Elvira
    Guardascione, Maria A.
    Margaglione, Maurizio
    BLOOD COAGULATION & FIBRINOLYSIS, 2008, 19 (05) : 459 - 462
  • [50] JAK2 V617F mutation induces a myeloproliferative disorder in mice.
    Bumm, TGP
    Elsea, C
    Wood, LG
    Sherbenou, DW
    Griswold, IJ
    Loriaux, M
    Druker, BJ
    Deininger, MW
    BLOOD, 2005, 106 (11) : 114A - 114A
12345